Drug Trial Radar · NCT00466388
Study of the Effectiveness of Cevimeline on Oral Health in Patients With Radiation Induced Xerostomia
Last checked: Nov 20, 2026Latest source record: May 22, 2014 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
54
Actual
Start
May 2007
Primary completion
Jun 2009
Study completion Aug 2009
Sponsor
- Lead sponsor
- American Academy of Otolaryngology-Head and Neck Surgery FoundationAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Duke University
- First posted
- Apr 24, 2007
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, care provider)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to determine the effectiveness of cevimeline (versus placebo) on the oral health of patients who have dry mouth which was caused by radiation therapy that was given for treatment of head and/or neck cancer.
Conditions
- Xerostomia
Interventions
CevimelineDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- To assess the impact of increased salivary flow due to treatment with cevimeline compared to placebo in patient reported oral health using the OHIP-49Time frame: 6 weeks
Locations
7 sites in 1 country. Site status is shown where the registry gives one.
Site not named
Colorado Springs, Colorado
Carle Clinic Association
Urbana, Illinois
University of Kansas Medical Center
Kansas City, Kansas
Commonwealth Ear, Nose and Throat
Louisville, Kentucky
Associated Otolaryngologist
Palmyra, Pennsylvania
University of Pittsburgh
Pittsburgh, Pennsylvania
Fauquier ENT Consultants
Warrenton, Virginia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.